Follow-up of low risk patients with papillary thyroid cancer: Role of neck ultrasonography in detecting lymph node metastases

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3402-3407

  Torlontano, Massimo ^a   Attard, Marco ^b   Crocetti, Umberto ^a   Tumino, Salvatore ^e   Bruno, Rocco ^c   Costante, Giuseppe ^f   D'Azzò, Girolamo ^b   Meringolo, Domenico ^d   Ferretti, Elisabetta ^g   Sacco, Rosario ^f   Arturi, Franco ^f   Filetti, Sebastiano ^g  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^c Tinchi Pisticci Hospital   (Italy)

^d Ospedale di Bentivoglio   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SIZE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK ULTRASONOGRAPHY; PALPATION; PAPILLARY CARCINOMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BIOPSY; CARCINOMA, PAPILLARY; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NECK; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; THYROXINE;

EID: 3242693043     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031521     Document Type: Article

References (24)

1. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306
2. Schlumberger MJ, Torlontano M 2000 Papillary and follicular thyroid carcinoma. Baillieres Clin Endocrinol Metab 14:610-613
3. Hay I, Bergstralh E, Goellner J, Ebersold J, Grant C 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058
4. Mazzaferri EL, Kloos RT 2001 Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463
5. Singer P, Cooper D, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG 1996 Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 156:2165-2172
6. Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP 1986 Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63:960-967
7. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R 2003 Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90-96
8. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M 2000 Is diagnostic iodine-131 useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175-178
9. Mazzaferri EL, Kloos RT 2002 Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 87:1490-1498
10. 131I scanning. J Clin Endocrinol Metab 87:1486-1489
11. Pacini F, Capezzone M, Elisei R, Ceccarelli C, Taddei D, Pinchera A 2002 Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87:1499-1501
12. 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. Eur J Endocrinol 148:19-24
13. Torrens JI, Burch HB 2001 Serum thyroglobulin measurement. Utility in clinical practice. Endocrinol Metab Clin North Am 30:429-467
14. Pacini F, Molinaro E, Lippi F, Castagna MG, Agate L, Ceccarelli C, Taddei D, Elisei R, Capezzone M, Pinchera A 2001 Prediction of disease status by recombinant human TSH-stimulated serum Tg in the post-surgical follow-up of differentiated thyroid carcinoma. J Clin Endocrinol Metab 86:5686-5690
15. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A 2003 Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88:3668-3673
16. American Joint Committee on Cancer 2002 Thyroid. In: Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M, eds. AJCC cancer staging handbook, chap 8. 6th Ed. New York: Springer; 89-98
17. Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, Ain KB, Bigos ST, Brierley JD, Haugen BR, Klein I, Robbins J, Sherman SI, Taylor T, Maxon HR 1998 Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 8:737-744
18. Antonelli A, Miccoli P, Ferdeghini M, Di Coscio G, Alberti B, Iacconi P, Baldi V, Fallahi P, Baschieri L 1995 Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid 5:25-28
19. Russo D, Arturi F, Pontecorvi A, Filetti S 1999 Genetic analysis in fine needle aspiration of the thyroid: a new tool for the clinic. Trends Endocrinol Metab 10:280-285
20. Arturi F, Russo D, Giuffrida D, Ippolito A, Perrotti N, Vigneri R, Filetti S 1997 Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 82:1638-1641
21. Yokoyama N, Nagayama Y, Kakezono F 1986 Determination of the volume of the thyroid gland by a high resolutional ultrasonic scanner. J Nucl Med 27:1475-1479
22. 131I activities versus untreated patients. J Clin Endocrinol Metab 86:4092-4097
23. Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M 2003 Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 88:1107-1111
24. Bachelot A, Cailleux AF, Klain M. Baudin E, Ricard M, Bellon N, Caillou B, Travagli JP, Schlumberger M 2002 Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 12:707-711